Shields JM - Search Results

1

Use of retrovirus expression of interfering RNA to determine the contribution of activated K-Ras and ras effector expression to human tumor cell growth.

Baines AT, Lim KH, Shields JM, Lambert JM, Counter CM, Der CJ, Cox AD. Baines AT, et al. Among authors: shields jm. Methods Enzymol. 2006;407:556-74. doi: 10.1016/S0076-6879(05)07045-X. Methods Enzymol. 2006. PMID: 16757353

2

Identification of Ras-regulated genes by representational difference analysis.

Shields JM, Der CJ, Powers S. Shields JM, et al. Methods Enzymol. 2001;332:221-32. doi: 10.1016/s0076-6879(01)32205-x. Methods Enzymol. 2001. PMID: 11305099

3

Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways.

Shields JM, Rogers-Graham K, Der CJ. Shields JM, et al. J Biol Chem. 2002 Mar 22;277(12):9790-9. doi: 10.1074/jbc.M110086200. Epub 2001 Dec 28. J Biol Chem. 2002. PMID: 11773051 Free article.

4

Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.

Shields JM, Mehta H, Pruitt K, Der CJ. Shields JM, et al. Mol Cell Biol. 2002 Apr;22(7):2304-17. doi: 10.1128/MCB.22.7.2304-2317.2002. Mol Cell Biol. 2002. PMID: 11884615 Free PMC article.

5

Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells.

Pruitt K, Ulkü AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, Shields JM. Pruitt K, et al. Among authors: shields jm. J Biol Chem. 2005 Jun 17;280(24):23363-70. doi: 10.1074/jbc.M503083200. Epub 2005 Apr 14. J Biol Chem. 2005. PMID: 15831492 Free article.

6

Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.

Shields JM, Thomas NE, Cregger M, Berger AJ, Leslie M, Torrice C, Hao H, Penland S, Arbiser J, Scott G, Zhou T, Bar-Eli M, Bear JE, Der CJ, Kaufmann WK, Rimm DL, Sharpless NE. Shields JM, et al. Cancer Res. 2007 Feb 15;67(4):1502-12. doi: 10.1158/0008-5472.CAN-06-3311. Cancer Res. 2007. PMID: 17308088

7

Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth.

Hao H, Muniz-Medina VM, Mehta H, Thomas NE, Khazak V, Der CJ, Shields JM. Hao H, et al. Among authors: shields jm. Mol Cancer Ther. 2007 Aug;6(8):2220-9. doi: 10.1158/1535-7163.MCT-06-0728. Mol Cancer Ther. 2007. PMID: 17699719

8

Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.

Kimple RJ, Vaseva AV, Cox AD, Baerman KM, Calvo BF, Tepper JE, Shields JM, Sartor CI. Kimple RJ, et al. Among authors: shields jm. Clin Cancer Res. 2010 Feb 1;16(3):912-23. doi: 10.1158/1078-0432.CCR-09-1324. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103665 Free PMC article.

9

Understanding Ras: 'it ain't over 'til it's over'.

Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Shields JM, et al. Trends Cell Biol. 2000 Apr;10(4):147-54. doi: 10.1016/s0962-8924(00)01740-2. Trends Cell Biol. 2000. PMID: 10740269 Review.

10

Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling.

Huntington JT, Shields JM, Der CJ, Wyatt CA, Benbow U, Slingluff CL Jr, Brinckerhoff CE. Huntington JT, et al. Among authors: shields jm. J Biol Chem. 2004 Aug 6;279(32):33168-76. doi: 10.1074/jbc.M405102200. Epub 2004 Jun 7. J Biol Chem. 2004. PMID: 15184373 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters